Normal and leukemic CD34-negative human hematopoietic stem cells

Reviews in Clinical and Experimental Hematology

Volumn 5, Issue 1, 2001, Pages 42-61

  Bonnet, Dominique ^a  

^a Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; SIALOMUCIN;

ANIMAL CELL; ANTIGEN EXPRESSION; CELL DIFFERENTIATION; CELL LINEAGE; CLONOGENESIS; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA; MOUSE; NONHUMAN; REVIEW;

ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA;

EID: 0035272681     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-0734.2001.00028.x     Document Type: Review

References (128)

1. Till JE and McCulloch EA. Hemopoietic stem cell differentiation. Biochem Biophys Acta, 605: 431-459, 1980.
2. Hodgson GS and Bradley TR. Properties of hematopoietic stem cells surviving 5-fluorouracil treatment. Nature, 281: 381-384, 1979.
3. Spangrude GJ, Heimfield S, Weissman IL. Purification and characterization of murine hematopoietic stem cells. Science, 241: 58-63, 1988.
4. Spangrude GJ and Johnson JR. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA, 87: 7433-7440, 1990.
5. Morrison SJ and Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity, 1: 661-673, 1994.
6. Sutherland HJ, Lansdorp PM, Henkelman DH, et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA, 87: 3584-3588, 1990.
7. Sutherland HJ, Eaves CJ, Eaves AC. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood, 74: 1563-1570, 1989.
8. Ploemacher RE, van der Sluijs JP, Voerman JS, Brons NH. An in vitro limiting dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood, 74: 2755-2764, 1989.
9. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia, 8: 1095-1102, 1994.
10. Hao QL, Thiemann FT, Petersen D, et al. Extended long term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood, 88: 3306-3310, 1996.
11. - cells with both lymphoid and myeloid potential. Blood, 91: 4145-4152, 1998.
12. - progenitors give rise to NK cells, B-lineage cells, dendritic cells and myeloid cells. Blood, 93: 96-105, 1999.
13. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA, 89: 2804-2810, 1992.
14. Punzel M, Wissink JS, Miller KA, et al. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood, 93:3750-3756, 1999.
15. Phillips R. Hematopoietic stem cells: Concepts, assays, and controversies. Semin Immunol, 3: 337-347, 1991.
16. Srour EF, Zanjani ED, Cornetta K, et al. Persistence of human multilineage, selfrenewing lymphohematopoietic stem cells in chimeric sheep. Blood, 82: 3333-3339, 1993.
17. Zanjani ED, Almeida-Porada G, Ascensao JL, et al. Transplantation of hematopoietic stem cells in utero. Stem Cells, 15 (Suppl. 1): 79-84, 1997.
18. McCune JM. Development and applications of the SCID-hu mouse model. Semin Immunol, 8: 187-196, 1996.
19. Torbett BE, Picchio G, Mosier DE. Hu-PBLSCID mice: A model for human immune function, AIDS, and lymphomagenesis. Immunol Rev, 124: 139-164, 1991.
20. Dick JE. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol, 8: 197-206, 1996.
21. Lapidot T, Pflumio F, Doedens M, et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science, 255: 1137-1141, 1992.
22. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in immunedeficient SCID mice. Blood, 83: 2489-2497, 1994.
23. Cashman JD, Lapidot T, Wang JCY, et al. Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood, 89: 4307-4316, 1997.
24. Pflumio F, Izac B, Katz A, et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood, 88: 3731-3740, 1996.
25. Hogan CJ, Shpall EJ, McNutty O, et al. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood, 90: 85-96, 1997.
26. Rottman GA, Shultz LD, Civin CI. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp Hematol, 26: 332-344, 1998.
27. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunological function in NOD/LtSz-scid mice. J Immunol, 154: 180-191, 1995.
28. Gan O, Murdoch B, Larochelle A, et al. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture marrow stromal cells. Blood, 2: 641-650, 1997.
29. Dao MA and Nolta JA. Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction. Int J Mol Med, 1: 257-264, 1998.
30. Nolta JA, Dao MA, Wells D, et al. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA, 93: 2414-2420, 1996.
31. Kollet O, Peled A, Byk T, et al. β2 microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood, 95: 3102-3105, 2000.
32. Shultz LD, Lang PA, Christianson SH, et al. NOD/LtSz-Rag1null mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol, 164: 2496-2507, 2000.
33. Arevalo JMG, Ertl DC, Dao MA, et al. A new immunodeficient mouse strain: The nude NOD/SCID for human hematopoietic cell xenotransplantation. Blood, 94 (Suppl. 1): 129a, 1999.
34. Civin CI, Strauss LC, Browall C, et al. Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody against KG-1a cells. J Immunol, 133: 157-164, 1985.
35. Andrews RE, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of CD33 and CD34 antigen and light scatter. J Exp Med, 169: 1721-1731, 1989.
36. Krause DS, Fackler MJ, Civin CI, et al. CD34: Structure, biology, and clinical utility. Blood, 87: 1-13, 1996.
37. Healy L, May G, Gale K, et al. The stem cell antigen CD34 functions as a regulator of hematopoietic cell adhesion. Proc Natl Acad Sci USA, 92: 12240-12244, 1995.
38. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in hematopoietic cell lines, brain, and embryonic fibroblasts. Int Immunol, 3: 75-84, 1991.
39. Simmons DL, Satterwaite AB, Tenen DG, Seed BJ. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol, 148: 267-271, 1992.
40. + marrow cells in patients with breast cancer or neuroblastoma. Blood, 77: 1717-1722, 1991.
41. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77: 400-409, 1991.
42. Fina L, Molgaard HV, Roberston D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood, 75: 2417-2426, 1990.
43. Baumhueter S, Dybdal N, Kyle C, et al. Global expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood, 84: 2554-2565, 1994.
44. Greaves MF, Brown J, Molgaard HV, et al. Molecular features of CD34: A hematopoietic progenitor cell-associated molecule. Leukemia, 6 (Suppl. 1): 31-36, 1992.
45. Suda J, Sudo T, Ito M, et al. Two types of murine CD34 mRNA generated by alternative splicing. Blood, 79: 2288-2294, 1992.
46. Krause DS, Ito T, Fackler M, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood, 84: 691-702, 1994.
47. Morel F, Szilvassy S, Travis M, et al. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen. Blood, 88: 3774-3782, 1996.
48. - hematopoietic stem cell populations. Exp Hematol, 27: 788-792, 1999.
49. + cells in serum-free cultures initiated with highly purified progenitor from human bone marrow. J Exp Med, 175: 1501-1509, 1992.
50. Craig W, Kay R, Cutler RB, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med, 177: 1331-1342, 1993.
51. Yin AH, Miraglia S, Zanjani EM, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90: 5002-5012, 1997.
52. Ziegler BL, Valtieri M, Almeida-Porada G, et al. KDR receptor: A key marker defining hematopoietic stem cells. Science, 285: 553-558, 1999.
53. Thomas TE, Miller CL, Eaves CJ. Purification of hematopoietic stem cells for further biological study. Methods, 17: 202-218, 1999.
54. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med, 2: 1329-1335, 1996.
55. Bhatia M, Wang JCY, Kapp U, et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA, 94: 5320-5325, 1997.
56. Cheng J, Baumhueter S, Cacalano G, et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood, 87: 479-484, 1996.
57. Suzuki A, Andrew DP, Gonzalo JA, et al. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90Kd protein. Blood, 87: 3550-3562, 1996.
58. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science, 273: 242-245, 1996.
59. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 183: 1797-1806, 1996.
60. Jones RJ, Collector MI, Barber JP, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood, 88: 487-491, 1996.
61. Goodell MA, Trischmann T, Kadan NS, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med, 3: 1337-1345, 1997.
62. + cells. Exp Hematol, 26: 353-360, 1998.
63. Bhatia M, Bonnet D, Murdoch B, et al. Identification of a newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med, 4: 1038-1044, 1998.
64. + bone marrow cells. Exp Hematol, 26: 440-446, 1998.
65. Goodell MA. CD34 (+) or CD34 (-): Does-it matter? Blood, 94: 2545-2548, 1999.
66. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood, 94: 2548-2554, 1999.
67. Taranenko N and Krause DS. Regulation of CD34 transcription by Sp1 requires sites upstream and downstream of the transcription start site. Exp Hematol, 28: 974-984, 2000.
68. Fackler MJ, Civin CI, May WS. Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem, 267: 17540-17545, 1992.
69. Tajima F, Sato T, Laver JH, Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colonystimulating factor. Blood, 96: 1989-1993, 2000.
70. Ito T, Tajimi F, Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp Hematol, 28: 1269-1273, 2000.
71. Dao MA and Nolta JA. CD34: To select or not to select? That is the question. Leukemia, 14: 773-776, 2000.
72. Dao MA and Nolta JA. Immunodeficient mice as models of human hematopoietic stem cell engraftment. Curr Opin Immunol, 11: 532-537, 1999.
73. Dao MA and Nolta JA. Reversibility of CD34 expression on human stem cells that retain the capacity for secondary reconstitution. Blood, 96: 581a, 2000.
74. - cells stimulated by multiple growth factors. Blood, 94: 1926-1932, 1999.
75. - hematopoietic cells. Blood, 94: 4053-4058, 1999.
76. Fialkow PJ, Singer JW, Raskind WH, et al. Clonal development, stem-cell differentiation, and clinical remission in acute nonlymphocytic leukemia. N Engl J Med, 317: 468-473, 1987.
77. Sabbath KD, Ball ED, Larcom P, et al. Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest, 75: 746-750, 1985.
78. Grier H and Civin C. Acute and chronic myeloproliferative disorders and myelodysplasia. Hematol Infancy Childhood, 2: 1288-1318, 1993.
79. McCulloch EC, Izaguirre CA, Chang LJ, Smith LJ. Renewal and determination in leukemic blast populations. J Cell Physiol Suppl, 1: 103-111, 1982.
80. McCulloch E. Stem cells in normal and leukemic hematopoiesis (Henry Stratton Lecture). Blood, 62: 1-6, 1983.
81. Griffin J and Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood, 68: 1185-1195, 1986.
82. Löwenberg B and Touw J. Hematopoietic growth factors and their receptors in acute leukemia. Blood, 81: 281-292, 1993.
83. Fialkow PJ, Singer JW, Adamson JW, et al. Acute nonlymphocytic leukemia: Heterogeneity of stem cell origin. Blood, 57: 1068-1073, 1981.
84. Bartram CR, Ludwig WD, Hiddemann W, et al. Acute myeloid leukemia: Analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia, 3: 247-256, 1989.
85. van Lom K, Hagemeijer A, Smit EM, Lowenberg B. In situ hybridization on May-Grunwald-Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities. Blood, 82: 884-888, 1993.
86. Fearon E, Burke P, Schiffer C, et al. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphoblastic leukemia. N Engl J Med, 315: 15-24, 1986.
87. Feuring-Buske M, Haase D, Konenmann S, et al. Trisomy 4 in "stem cell-like" leukemic cells of a patient with AML. Leukemia, 9: 1318-1320, 1995.
88. Greaves MF. Stem cell origins of leukaemia and curability. Br J Cancer, 67: 413-423, 1993.
89. Keinänen M, Griffin J, Bloomfield C, et al. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N Engl J Med, 318: 1153-1158, 1988.
90. McCulloch EA, Kelleber CA, Miyauchi J, et al. Heterogeneity in acute myeloblastic leukemia. Leukemia, 2 (Suppl. 1): 38S-49S, 1988.
91. Griffin JD, Larcom P, Schlossman SF. Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. Blood, 62: 1300-1306, 1983.
92. + subpopulations. Blood, 86: 2906-2912, 1995.
93. -) in acute myeloid leukemia. Blood, 86: 1139-1147, 1995.
94. Lapidot T, Sirard C, Voormor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367: 645-648, 1994.
95. Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3: 730-737, 1997.
96. Sutherland HJ, Blair A, Zapf RW. Characterization of a hierarchy in human acute myeloid progenitor cells. Blood, 87: 4754-4761, 1996.
97. Ailles LE, Gerhard B, Kawagoe H, et al. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood, 94: 1761-1772, 1999.
98. Terpstra W, Prins A, Ploemacher RE, et al. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood, 87: 2187-2194, 1996.
99. Terpstra W, Ploemacher RE, Prins A, et al. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood, 88: 1944-1950, 1996.
100. -. Blood, 92: 4325-4335, 1998.
101. Blair A, Hogge DE, Ailles LE, et al. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long term proliferative ability in vitro and in vivo. Blood, 89: 3104-3112, 1998.
102. Brendel C, Mohr B, Schimmelpfennig C, et al. Detection of cytogenetic aberrations both in CD90 (Thy.1)-positive and (Thy.1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias. Leukemia, 13: 1770-1775, 1999.
103. Jordan CT, Upchurch D, Szilvassy SL, et al. The interleukin-3 receptor alpha chain is a unique marker for human myelogenous leukemia stem cells. Leukemia, 14: 1777-1784, 2000.
104. Guan Y and Hogge DE. Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML). Leukemia, 14: 2135-2141, 2000.
105. Russell NH, Hunter AE, Bradbury D, et al. Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukaemia. Leuk Lynphoma, 16: 223-229, 1995.
106. Strom DK, Nip J, Westendorf JL, et al. Expression of AML-1 oncogene shortens the (G1) phase of the cell cycle. J Biol Chem, 275: 3438-3445, 2000.
107. Bonnet D, Xu Y, Luongo J. Heterogeneity at the leukemic stem cell level. Blood, 94 (Suppl. 1): 659a, 1999.
108. Wulf RY, Wang I, Kuenhnle D, et al. Leukemia involvement of the CD34 negative bone marrow side population (SP) in patients with AML. Blood, 94 (Suppl. 1): 66a, 1999.
109. - repopulating cells. Blood, 16: 492a, 2000.
110. Guenechea G, Gan O, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol, 2: 75-82, 2000.
111. Phillips RL, Ernst RE, Brunk B, et al. The genetic program of hematopoietic stem cells. Science, 288: 1635-1640, 2000.
112. Ferrari G, Cusella-DeAngelis G, Coletta M, et al. Muscle regeneration of bone marrow derived myogenic progenitors. Science, 279: 1528-1530, 1998.
113. Gussoni E, Soneaoka Y, Stickland C, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401: 390-394, 1999.
114. Petersen B, Bowen W, Pattiene L, et al. Bone marrow as a potential source of hepatic oval cells. Science, 284: 1168-1170, 1999.
115. Theise ND, Badve S, Saxena R, et al. Derivation of hepatocyte from bone marrow cells in mice after radiation-induced myeloablation. Hepatocyte, 31: 235-240, 2000.
116. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from marrow in humans. Hepatocyte, 32: 11-16, 2000.
117. Woodbury D, Schwarz EJ, Prockop D, Black IR. Adult rat and marrow stromal cells differentiate into neurons. J Neurosci Res, 61: 364-370, 2000.
118. Jackson K, Mi T, Goodell M. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA, 96: 14482-14486, 1999.
119. Bjornson CR, Rietze RL, Reynolds BA, et al. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science, 283: 534-538, 1999.
120. Eglitis MA and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA, 94: 4080-4085, 1997.
121. Eguchi G and Kodama R. Transdifferentiation. Curr Opin Cell Biol, 5: 1023-1028, 1993.
122. Wel G, Schubiger G, Harder F, Muller AM. Stem cell plasticity in mammals and transdetermination in drosophilia: Common themes? Stem Cells, 18: 409-414, 2000.
123. Pittenger MF, MacKay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 284: 143-147, 1999.
124. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science, 276: 71-74, 1997.
125. - hematopoietic and mesenchymal stem cells from various sources. Stem Cells, 18: 1-9, 2000.
126. Nutt S, Heavey B, Rolink A, et al. Commitment of the B-lymphoid lineage depends on the transcription factor Pax5. Nature, 401: 556-562, 1999.
127. Cossu G and Mavilio F. Myogenic stem cells for therapy of primary myopathies: Wishful thinking or therapeutic perspective? J Clin Invest, 105: 1669-1674, 2000.
128. Moore MA. "Turning brain into blood" - Clinical applications of stem cell research in neurobiology and hematology. N Engl J Med, 341: 605-607, 1999.